These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2015161)

  • 1. A study of adjunctive copper sulphate treatment in patients with rheumatoid arthritis who have relapsed while taking D-penicillamine.
    Pullar T; Wrigley H; Newton K; Toothill C; Wright V
    Br J Clin Pharmacol; 1991 Jan; 31(1):105-7. PubMed ID: 2015161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment].
    Crouzet J; Nafziger J; Guillien P; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1973; 40(7):485-9. PubMed ID: 4756424
    [No Abstract]   [Full Text] [Related]  

  • 3. Penicillamine metal chelates and their possible importance in rheumatoid arthritis--a brief review.
    Davis P
    Clin Invest Med; 1984; 7(1):41-4. PubMed ID: 6723123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
    Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
    Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased taste sensitivity after D-penicillamine reversed by copper administration.
    Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH
    Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
    Williams HJ; Ward JR; Reading JC; Egger MJ; Grandone JT; Samuelson CO; Furst DE; Sullivan JM; Watson MA; Guttadauria M; Cathcart ES; Kaplan SB; Halla JT; Weinstein A; Plotz PH
    Arthritis Rheum; 1983 May; 26(5):581-92. PubMed ID: 6342625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The copper chelating effect of D-penicillamine in the long-term therapy of progressive chronic polyarthritis].
    Krüger HH
    Med Klin; 1970 Apr; 65(14):650-2. PubMed ID: 4994367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with D-penicillamine].
    Miehlke K
    Arzneimittelforschung; 1971 Nov; 21(11):1815-7. PubMed ID: 5171812
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary copper excretion in rheumatoid arthritis.
    McMurray W; Martin VM; Scudder P; Stocks J; White AG; Dormandy TL
    Ann Rheum Dis; 1975 Aug; 34(4):340-5. PubMed ID: 1190853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-penicillamine withdrawal in rheumatoid arthritis.
    Ahern MJ; Hall ND; Case K; Maddison PJ
    Ann Rheum Dis; 1984 Apr; 43(2):213-7. PubMed ID: 6370151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper penicillaminate for rheumatoid arthritis?
    Scheinberg IH
    J Rheumatol Suppl; 1981; 7():178-9. PubMed ID: 6939883
    [No Abstract]   [Full Text] [Related]  

  • 19. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement.
    Hansen TM; Manthorpe R; Kofod B; Andreassen T; Oxlund H; Lorenzen IB
    J Rheumatol; 1976 Dec; 3(4):367-74. PubMed ID: 1022870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.